Many studies have shown that worry varies by sociodemographic factors 5, 14, 17, 18 ; however, most prior studies have been limited by small, clinic-based samples, using inconsistent measures. A major gap in knowledge is whether worry differs across racial/ethnic groups, including Latinos. Although Latinos are a racially and socioculturally heterogeneous population, 19 cultural commonalities exist, including shared language, health beliefs, and healthcare system experiences that impact health and QOL outcomes. 20 Two studies report that Latinas have more worry than other groups, 15, 17 but these studies do not consider the role of acculturation. When acculturation has been measured across other health outcomes, Latinas with low acculturation experience more delay, 10 lower decision satisfaction, 9 and greater difficulty with physician-patient communication. 21 The association between clinical/treatment factors and worry also needs to be further explored. Some studies suggest more comorbidities and symptoms contribute to greater worry, 7, 22 whereas others have found that receiving chemotherapy may be associated with worry. 3, 14, 23 Finally, few studies have examined factors in the healthcare experience (eg, care coordination) that might elucidate differences in worry across vulnerable subgroups. Negotiating the healthcare system remains an understudied element of acculturation. 24 By better understanding the influence of cultural adaptation on health and disease, modifiable factors can be identified, high-risk populations targeted, and interventions tailored to specific components affecting risk. 24 To address these gaps in the literature, we used a large multiethnic population-based sample of women with breast cancer to examine the following questions. 1) What are the sociodemographic, clinical, and treatment correlates of reported worry about recurrence as women transition into breast cancer survivorship? 2) Is patients' appraisal of their healthcare experience associated with worry about recurrence, and does it mediate the relationship between worry and sociodemographic, clinical, and treatment factors? 3) Are sociodemographic correlates of worry about recurrence modified by factors related to the healthcare experience? 
MATERIALS AND METHODS

Study Population
Population Sampling and Data Collection
Eligible breast cancer patients were accrued via rapid case ascertainment as they were reported to the LA Cancer Surveillance Program and the Metropolitan Detroit Cancer Surveillance System. All African American women were selected on demographic information from the treating hospitals. Latina women in LA were selected by including all women designated as Hispanic by the hospital, as well as all women whose surname indicated a high probability of being Latina, based on a list generated from the 1980 US Census. A random sample of the remaining white patients in LA and Detroit were selected to reach the targeted accrual number. Asian women in LA were excluded because they were enrolled in other studies. Physicians were notified of our intent to contact their patients. If no objection was received, the patients were mailed an introductory letter, survey materials, and a $10 cash gift. Women from LA likely to be Latina based on the US Spanish Surname list were sent both English and Spanish materials. The Spanish survey was not used in Detroit because few Hispanic women ($50) were diagnosed with breast cancer and reported to the SEER registry during the study. 26 The Dillman survey method was used to encourage survey response. 27 The study protocol was approved by the institutional review boards of the University of Michigan, University of Southern California, and Wayne State University.
Survey Measures
The questionnaire was developed based on prior research in the target population. 9, 10, 23 Extensive piloting was done with both English and Spanish versions. The Spanish survey was developed using rigorous translation approaches including forward/back techniques to ensure congruency between surveys. Internal consistency tests were used to assess reliability of measures.
A modified stress/appraisal theoretical framework 28, 29 adapted from Lazarus 28 and used by Northouse et al 29 guided our survey ( Fig. 1) . According to the framework, there are antecedent variables (eg, person, illness related) and mediating variables (eg, appraisal factors) that directly or indirectly affect QOL. We identified antecedent variables (categorized into person and clinical/ treatment factors) and mediating factors (appraisal of healthcare experience) potentially affecting worry.
Dependent Variable
Worry about recurrence was assessed with 3 items regarding worry about cancer: 1) coming back in the same breast, 2) occurring in the other breast, and 3) spreading to other parts of the body. The 5-point Likert response scale for each item ranged from ''not at all'' to ''very much,'' with good internal consistency (Cronbach alpha ¼ .88). We created an overall worry about recurrence score as the mean across items (higher scores indicate more worry; range 1-5).
Independent Variables
Antecedent factors
Survey information on race and ethnicity was combined to create the race/ethnicity variable. Women indicated their race (white, black/African American, American Indian or Alaska Native, Asian or Pacific Islander, or other) and whether they were Hispanic/Latina (yes/no). The Short Acculturation Scale for Hispanics, developed by Marin and colleagues, 30 is a widely used, reliable, and valid measure to identify level of acculturation. 31, 32 The 4 items in the Short Acculturation Scale for Hispanics indicate preference for English or Spanish in different contexts (usually read/speak, think, use at home, use with friends) on a 5-point scale (''English only'' to ''Spanish only''). We aggregated across items to calculate a mean score. Fifty-five percent of Latina patients scored 4 on the 5-point scale (strongly preferring Spanish Clinical factors included family history of breast cancer (first degree, no first degree) number of comorbidities (0, 1, 2 or more), frequency of symptoms during treatment (pain and fatigue on a 5-point Likert scale, ''not at all'' to ''very much''), and stage at diagnosis (0, I, II/III). Breast cancer stage was obtained via SEER data using the American Joint Committee on Cancer criteria. 25 Treatment factors included surgical procedure (lumpectomy or mastectomy), radiation therapy (yes/no), and chemotherapy (yes/no).
Mediating factors
The patients' appraisal of their healthcare experience was measured across 3 factors: 1) ease of understanding information, 2) symptom management, and 3) care coordination. Ease of understanding information was measured as the mean response to 2 items (5-point Likert scale, from never to always): 1) ''How often did you have problems understanding information about your breast cancer and its treatment because of difficulty with written information?'' and 2) 'How often did you have someone (like a family member, hospital/clinic worker, or caregiver) help you read written information from the hospital or clinic?'' This scale ranged from 1 to 5, with a mean of 4.32, and Cronbach alpha of .652. Symptom management was the response to the question, ''Do you think your doctor(s) and their staff did everything they could to help you manage your symptoms'' (5-point Likert scale from ''not at all'' to ''very much''). This measure ranged from 1 to 5, with a mean of 4.06. The care coordination items were based on the Agency for Healthcare Research and Quality 33 report and other cancer quality of care literature. 34 The measure was the mean response to 5 items (5-point Likert scale, never to always): 1) how often patients received help from their surgeons with referrals to other physicians, 2 2) how often they knew whom to ask when they had questions, 3) how often they were given confusing advice (reverse coded), 4) how often they knew what the next step in their treatment was, and 5) how often their physicians had the medical information they needed. The care coordination scale ranged from 1 to 5, with a mean of 4.50 and Cronbach alpha of .697. Higher scores for all 3 healthcare experience measures indicate more understanding of information, better symptom management, and better coordination of care. Multi-item scale scores were calculated by averaging items. Each healthcare experience measure was collapsed into 3 ordinal categories (low, medium, high) to optimize the clarity of presentation. Other specifications of these variables (eg, interval scale) yielded similar results.
Analysis Plan
Of the 2268 available for analysis, we omitted 431 (19.4%) women with missing values for any variable in the analyses; thus, the final analytic sample included 1837 women. Sample weights were included to adjust for design effects resulting from differential selection by race/ ethnicity and nonresponse. Descriptive statistics were used to characterize the distribution of study covariates overall and by mean worry score. Bivariate associations were investigated between worry and sociodemographics, clinical/treatment, and healthcare system factors. We also tested bivariate associations between sociodemographics and factors within the healthcare experience, an important step is assessing mediation. Multivariate regression models investigated associations in a sequential modeling by including sociodemographics and clinical/treatment factors in Model 1, and then adding the potential mediating factors related to the healthcare experience in Model 2 (Research Question 2). All 2-way interactions between sociodemographics and healthcare experience factors were examined testing a moderating role (Research Question 3). All analyses were performed using SAS V9 programming (SAS Institute, Cary, NC). Table 1 displays the sample characteristics overall and by mean worry scores. The mean age was 56.8 years (standard deviation ¼ 11.4), and 68.7%, 14.3%, 8.1%, and 8.9% were white, African American, Latinas-high, and Latinas-low, respectively. In bivariate analyses, there were significant differences in mean worry scores (all P values <.001) for all sociodemographic variables except level of income. Women who were younger, Latina, employed, married, and less educated had higher levels of worry. More worry was also reported by women with higher cancer stage, fewer comorbidities, and more frequent pain and fatigue during treatment (all Ps < .05). Women who had lumpectomy compared with mastectomy reported more worry, as did women who received radiation and/or chemotherapy (all Ps < .05).
RESULTS
For the total sample, item mean levels of worry were distributed as follows: 14% ''not at all,'' 32% ''a little bit,'' 25% ''somewhat,'' 16% ''quite a bit,'' and 14% ''very much.'' Figure 2 shows the percentage of women reporting levels of worry by race/ethnicity. Almost 29% of African American women expressed low levels of worry (corresponding to ''not at all''), compared with about 10%, 19%, and 20% for Latinas-low, Latinas-high, and whites, respectively. Alternatively, almost 46% of Latinaslow reported the highest category of worry (''very much'') compared with 25%, 13%, and 14% for Latinas-high, African American, and white women, respectively. Figure 3 displays unadjusted mean worry scores for the 3 healthcare experience factors. Greater ease in understanding information (3.14, 3.01, 2.68 for low, medium, and high, P < .001), better symptom management (3.31, 2.85, 2.76 for low, medium, and high, P ¼ .001), and more coordinated care (3.39, 2.91, 2.73, for low, medium, and high, P < .001) were all significantly associated with lower levels of worry.
In the multivariate findings (Table 2) , where Model 1 adjusted for sociodemographic and clinical/treatment factors, worry scores were significantly associated with race/ethnicity, age, employment status, frequency of pain and fatigue, and receipt of radiation therapy (all Ps < .05). More worry was reported by Latinas (low and high) than whites, and women who were younger, were employed, had more comorbidities, had more pain and fatigue, and who received radiation. In Model 2, which further adjusted for the 3 factors from the healthcare experience, associations were only slightly reduced for sociodemographic, clinical, and treatment factors, with the exception of the number of comorbidities, where the associations were reduced and no longer significant (P ¼ .091). In this model, Latinas-low reported more worry than other groups, with a worry score of 3.80 versus 3.17, 2.59, and 2.90 for Latinas-high, African Americans, and whites (P < .001). Although worry continued to be significantly higher for Latinas-high than whites, the magnitude of the differences were small, suggesting differences may be a result of a large sample. African American women reported significantly less worry than whites. Model 2 also demonstrates associations between worry scores and patients' appraisal of their care experiences. Specifically, less worry was associated with greater ease of understanding information (P ¼ .047), better management of symptoms (P ¼ .044), and more coordinated care (P ¼ .012). We did not find any significant interactions between sociodemographics and healthcare experience factors, suggesting that sociodemographic factors and worry scores were not modified by healthcare experience factors.
DISCUSSION
In this diverse population-based sample of newly diagnosed breast cancer patients, race, ethnicity, and acculturation were associated with differences in worry about recurrence after controlling for other sociodemographic, clinical/treatment, and healthcare experience factors. Latinas-low reported substantially more worry than white women. Indeed, the mean difference was the largest observed in the study (nearly 1 point in the 5-point range). Several clinical studies with smaller samples reported that Latinas are more likely to express worry and 15, 17 but to our knowledge no previous study has examined worry by level of acculturation. In contrast, African American women reported lower levels of worry, lending support to the growing literature indicating that African American women report fewer concerns in the early survivorship period 17 and have higher emotional well-being than whites. 35 Consistent with previous studies, we found that younger women reported substantively more worry. 5, 14, 17, 23, 36, 37 Younger women likely have fewer peers with serious illness and find cancer more stressful, having fewer coping resources.
14 Whereas education did not remain significant in the full model, being employed was associated with more worry. Women who are employed may worry more because of the consequences of a recurrence on job stability.
Persistent pain and/or fatigue over the treatment period were strongly associated with more worry at survey completion. Possible explanations for this finding include that the symptoms persisted and triggered greater worry, 38 women had a heightened attentional focus on bodily sensations resulting in greater worry (ie, somatoform amplification), 39 and/or women who were anxious reported more symptoms. 40 In addition, the presence of comorbidities may make it more difficult to interpret whether symptoms are because of cancer, resulting in higher worry. Cancer stage was not independently associated with more worry, consistent with many other studies. 3, 14, 22, 41 Current health state may be a more powerful determinant of worry than actual prognosis. Similar to prior studies, we found that receipt of adjuvant therapy on subsequent worry was inconsistent. 3, 14, 22 Women who received radiation reported more worry, whereas in the final model receipt of chemotherapy did not remain significant. Vickberg 3 reasons that because younger women report more fear and are more likely to receive chemotherapy, chemotherapy is not significant when age is in the model. The impact of aggressive treatment on worry may vary depending on whether the treatment course is viewed as signaling more serious disease or as protection against recurrence. Radiation may have remained significant because skin reactions may still have been present for women receiving radiotherapy, serving as a reminder of their diagnosis and treatment.
This study explored whether women's appraisal of their care experiences was associated with worry. Previous studies suggest women are frequently dissatisfied with information they receive regarding recurrence 12 and generally desire more risk information. 42 Our study and those of others 21 support that difficulty understanding information and establishing a good relationship with their physician could contribute to greater worry. Although the presence of symptoms during treatment was associated with more worry later, women who perceived their symptoms were well managed reported less worry. Additional attention to symptom management by providers could be included in survivorship care plans and monitored at follow-up. The challenge is to ensure women's awareness of signs of recurrence while not increasing anxious preoccupation with excessive worry. 43 The IOM report on cancer survivors recommends patients receive a comprehensive care summary and follow-up plan to inform and coordinate delivery of care, 8, 44 which may lead to reduced worry, as supported by our findings.
Factors not measured in this study may explain why racial/ethnic differences in worry persisted after healthcare system experiences were assessed. Culture could impact communication styles and/or perceptions of worry. For African American women it may be culturally appropriate to present a strong image, thereby reporting less worry, whereas for Latinas it may be culturally appropriate to express concerns and greater distress. 17 Low acculturated Latinas may perceive a higher likelihood of recurrence, perceive the impact of a recurrence as more grave, or have greater concerns about the consequences of a recurrence. 3 Even controlling for insurance, education, and income, racial/ethnic differences persisted, with Latinas-low reporting more worry. Finally, cultural variations in coping may contribute to differences in worry. African American breast cancer survivors report more social support 18 and use more religious-oriented coping 17 than whites, whereas low acculturated Latinas report the lowest level of social support. 37, 42 Study findings are limited by the cross-sectional design that did not allow for examination of worry over time. Multiethnic longitudinal evaluations of worry are needed to inform effective interventions to reduce disparities. It should be noted that our measure did not assess the duration, frequency, and impact of distress on impairment. 3, 45 Although the validity of attitudes measures are difficult to fully evaluate, the worry measure was positively correlated with more symptoms during treatment, and correlated with our QOL measure (FACT-B) 46 subscales as follows: physical well-being scale, r ¼ À0.313 (P < .001); emotional well-being scale, r ¼ À0.577 (P < .001) (unpublished).
Our study measures were self-reported and may be subject to recall bias because of the time delay from treatment to survey completion. However, we made considerable effort to address response bias through a rigorous Original Article translation process and pilot testing. Our previous publications have also supported the marked differences between Latinas-low versus other groups across a broad array of outcomes. 9, 10, 35 Nevertheless, ethnicity and acculturation cannot be fully untangled because our acculturation measure was language based and only assessed in Latinas. A major study strength was the large populationbased sample with sufficient numbers of Latinas (predominately from Mexico and Central America) to examine the relevance of acculturation. Nevertheless, the US Hispanic population is diverse, and it is not appropriate to generalize our findings to Latinas from other cultural backgrounds.
Implications
Future research is needed to determine from whom, and under what circumstances, cancer patients are receiving risk information. We need to understand providers' perceptions about their responsibilities in informing and addressing patients' worries about recurrence. Validation of women's appraisal of the healthcare experience with the actual receipt of services is an important area for future research. Some of the mean differences we observed in worry between groups, although significant, were small, which may be a result of a large sample size. Further replication is needed to determine the clinical importance of some of these findings.
For women with excessive worry, appropriate referrals could be targeted at their unique concerns. These interventions must be culturally sensitive, and tailored to differences in communication style, social support, and coping strategies. Continuing research must recognize the multifaceted nature of women's fears, including racial/ ethnic variation and acculturation differences in worry. The influence of factors regarding a women's experience in the healthcare system deserves attention, as they hold promise for system and policy interventions.
